Abstract: A method is provided for formulating a personal cleansing composition. At least one primary surfactant, at least one secondary amphoteric and/or nonionic surfactant, at least one humectant, and at least one polymeric and/or quaternary conditioner are selected, each of these components having a natural and renewable resource origin. The primary and secondary surfactants are combined with the at least one humectant and the at least one conditioner in a final composition that includes the combined primary and secondary surfactants at less than about 14 wt. %, and includes the combined at least one humectant and at least one conditioner at less than 5.5 wt. %. After forming the final composition, an optimum performance index (OPI) is determined for the composition to ensure that the composition has an OPI of at least about 5.450. The OPI is calculated as: OPI=3÷((solids wt.%+Zein score)÷performance grade).

Abstract: A cleansing bar includes a surfactant-containing body, which includes a top surface, a bottom surface that is substantially opposite to the top surface, first and second ends, and first and second sides extending horizontally and meeting at the first and second ends to together define a perimeter around the cleansing bar between the top and bottom surfaces. A first horizontally-extending groove is formed in at least the first side surface. According to one embodiment, the first horizontally-extending groove extends only partially between the first and second ends. A second horizontally-extending groove is formed in the second side surface, and also extends only partially between the first and second ends. According to another embodiment, the first horizontally-extending groove is further formed around the first and second ends and in the second side surface to encircle the cleansing bar.

Abstract: A virulent preparation of Agrobacterium cells, includes Agrobacterium cells, an acidulant, and a phenolic compound that is preferably ethyl vanillin. A method of preparing the preparation includes the steps of preparing a suspension of Agrobacteria in a liquid desiccation medium which includes an acidulant and the phenolic compound and dehydrating the suspension. The preparation is shelf stable at ambient temperature for several months. The preparation may further contain a dry excipient material, a food coloring agent, a flow agent, a plant hormone, a bacterial growth promoter and an antifungal agent.

Abstract: A nontoxic, therapeutic agent having pharmacological activity comprising concentrated extract of Larrea tridentata plant material and ascorbic acid, an ascorbic acid ester, an ascorbic acid salt, butylated hydroxyanisole, butylated hydroxytoluene, hydrogen sulfide, hypophosphorous acid, monothioglycerol, potassium bisulfite, propyl gallate, sodium bisulfite, sodium hydrosulfite, sodium thiosulfate, sulfur dioxide, sulfurous acid, a tocopherol or vitamin E is made by a process in which the plant material is extracted using an organic solvent, preferably acetone, and is then saturated with one of the listed reducing agents acid to reduce the toxic NDGA quinone, which naturally occurs in the plant material, to NDGA itself.

Abstract: A nontoxic, therapeutic agent having pharmacological activity comprising concentrated extract of Larrea tridentata plant material and ascorbic acid, an ascorbic acid ester, an ascorbic acid salt, butylated hydroxyanisole, butylated hydroxytoluene, hydrogen sulfide, hypophosphorous acid, monothioglycerol, potassium bisulfite, propyl gallate, sodium bisulfite, sodium hydrosulfite, sodium thiosulfate, sulfur dioxide, sulfurous acid, a tocopherol, or vitamin E is made by a process in which the plant material is extracted using an organic solvent, preferably acetone, and is then saturated with one of the listed reducing agents acid to reduce the toxic NDGA quinone, which naturally occurs in the plant material, to NDGA itself.

Abstract: A nontoxic, therapeutic agent having pharmacological activity comprising concentrated extract of Larrea tridentate plant material and ascorbic acid is made by a process in which the plant material is extracted using an organic solvent, and is then saturated with ascorbic acid to reduce the toxic NDGA quinone, which naturally occurs in the plant material, to NDGA itself. Additional amounts of ascorbic acid are added to the extract to inhibit the natural oxidation of the NDGA into the toxic NDGA quinone in vivo, or during processing or storage. The resulting extract is useful in the treatment of viral diseases caused by viruses from the Herpesviridae family or viruses which require the Sp1 class of proteins to initiate viral replications. The resulting compound can also be used as an anti-inflammatory when the inflammatory diseases are mediated by the effects of leukotrienes. The listed reducing agents can also be used to stabilize NDGA as a therapeutic agent or a food additive.

Abstract: A nontoxic, therapeutic agent having pharmacological activity comprising concentrated extract of Larrea tridentata plant material and ascorbic acid, an ascorbic acid ester, an ascorbic acid salt, butylated hydroxyanisole, butylated hydroxytoluene, hydrogen sulfide, hypophosphorous acid, monothioglycerol, potassium bisulfite, propyl gallate, sodium bisulfite, sodium hydrosulfite, sodium thiosulfate, sulfur dioxide, sulfurous acid, a tocopherol, or vitamin E is made by a process in which the plant material is extracted using an organic solvent, preferably acetone, and is then saturated with one of the listed reducing agents acid to reduce the toxic NDGA quinone, which naturally occurs in the plant material, to NDGA itself.